The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis
EuroIntervention 2017;12:e2170-e2176 published online January 2017 published online e-edition April 2017. DOI: 10.4244/EIJ-D-16-00677
Stephane Noble1, MD; Stefan Stortecky2, MD; Dik Heg3, PhD; David Tueller4, MD; Raban Jeger5, MD; Stefan Toggweiler6, MD; Enrico Ferrari7, MD; Fabian Nietlispach8, MD; Maurizio Taramasso8, MD; Francesco Maisano8, MD; Jürg Grünenfelder9, MD; Peter Jüni10, MD; Christoph Huber1, MD; Thierry Carrel2, MD; Stephan Windecker2, MD; Peter Wenaweser2,11*, MD; Marco Roffi1, MD
1. Cardiology Division, University Hospital, Geneva, Switzerland; 2. Cardiology and Cardiovascular Surgery Departments, Swiss Cardiovascular Center, University Hospital, Bern, Switzerland; 3. Clinical Research Department, Clinical Trials Unit and Institut
Aims: Data on procedural and clinical outcomes after transcatheter aortic valve implantation (TAVI) with the new-generation self-expanding Medtronic Evolut R prosthesis in comparison with